Regeneron Pharmaceuticals, Inc. (REGN)
| Previous close | 502.60 |
| Open | 496.65 |
| Bid | 499.00 x 800 |
| Ask | 508.88 x 1100 |
| Day's range | 502.05 - 503.75 |
| 52-week range | 441.00 - 664.64 |
| Volume | 18,145 |
| Avg. volume | 1,011,079 |
| Market cap | 53.892B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 16.48 |
| EPS (TTM) | 30.52 |
| Earnings date | 06 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 643.36 |
- Motley Fool
3 Cathie Wood Stocks You Can Buy at a Bargain Right Now
When Cathie Wood talks, investors listen. The founder of Ark Invest has successfully predicted stock market stars -- one of her top holdings is Tesla. Now, here's some great news for all of us who want to follow this investment superstar's lead: Right now, you can buy three of the biggest holdings in her Ark Genomic Revolution ETF at a bargain.
- Motley Fool
Could Vir Biotechnology Be a Millionaire Maker Stock?
Vir Biotechnology (NASDAQ: VIR) may be weeks away from commercializing its very first product. The clinical-stage biotech company and partner GlaxoSmithKline late last month requested Emergency Use Authorization (EUA) for their investigational COVID-19 treatment. In more good news, GlaxoSmithKline recently expanded its collaboration with Vir to include the development of potential treatments for respiratory viruses including influenza.
- Yahoo Finance Video
Vaccinating kids will be very important in getting to herd immunity: Expert
Kristen Choi, PhD, MS, RN, Assistant Professor, UCLA School of Nursing, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.
